NCT03757234 - IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis | Biotech Hunter

Enrollment

201

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

June 26, 2019

Study Completion Date

July 24, 2019

Conditions

Acute Pyelonephritis

Interventions

DRUG

Omadacycline

po tablets

DRUG

Levofloxacin

iv solution/po tablets

DRUG

Omadacycline

iv solution

Trial Locations (31)

2660

Site 504, Kyiv

4053

Site 503, Kyiv

49005

Site 506, Dnipro

58001

Site 502, Chernivtsi

61037

Site 505, Kharkiv

69600

Site 507, Zaporizhzhia

79059

Site 501, Lviv

141435

Site 408, Moscow

194291

Site 411, Saint Petersburg

195067

Site 406, Saint Petersburg

196247

Site 402, Saint Petersburg

197022

Site 412, Saint Petersburg

197374

Site 403, Saint Petersburg

198205

Site 414, Saint Petersburg

198412

Site 401, Saint Petersburg

199106

Site 404, Saint Petersburg

214018

Site 413, Smolensk

344022

Site 407, Rostov-on-Don

344037

Site 405, Rostov-on-Don

440026

Site 415, Penza

660062

Site 409, Krasnoyarsk

Unknown

Site 201, Tbilisi

Site 202, Tbilisi

Site 203, Tbilisi

Site 204, Tbilisi

Site 301, Daugavpils

Site 305, Rēzekne

Site 302, Riga

Site 303, Valmiera

LV-3414

Site 304, Liepāja

Moscow

Site 410, Moscow